UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$850M |
| 2 |
Apple
AAPL
|
+$778M |
| 3 |
Tesla
TSLA
|
+$569M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$351M |
| 5 |
Johnson & Johnson
JNJ
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Meta Platforms (Facebook)
META
|
+$237M |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$223M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$217M |
| 5 |
Vertiv
VRT
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.83% |
| 2 | Healthcare | 7.49% |
| 3 | Financials | 7.15% |
| 4 | Consumer Discretionary | 4.92% |
| 5 | Industrials | 4.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4701
Vera Bradley
VRA
$96.7M
| $469K | ﹤0.01% |
103,501
+7,164
| +7% | +$26.2K |
|
4702
monday.com
MNDY
$3.99B
| $469K | ﹤0.01% |
3,843
+1,241
| +48% | +$129K |
|
|
RFP
4703
DELISTED
Resolute Forest Products Inc.
RFP
| $469K | ﹤0.01% |
21,706
+19,518
| +892% | +$408K |
|
4704
Invesco New York AMT-Free Municipal Bond ETF
PZT
$140M
| $468K | ﹤0.01% |
21,141
-2,949
| -12% | -$64.1K |
|
4705
Xtrackers FTSE Developed ex US Multifactor ETF
DEEF
$56.6M
| $467K | ﹤0.01% |
18,388
-6,625
| -26% | -$161K |
|
4706
Alpha and Omega Semiconductor
AOSL
$1.09B
| $466K | ﹤0.01% |
16,294
+5,958
| +58% | +$193K |
|
4707
CALL
MSCI
MSCI
$40.9B
| $465K | ﹤0.01% |
+1,000
| New | +$465K |
|
4708
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$367M
| $465K | ﹤0.01% |
15,690
+1,561
| +11% | +$44K |
|
4709
Cinemark Holdings
CNK
$4.32B
| $464K | ﹤0.01% |
53,533
-45,750
| -46% | -$516K |
|
|
FLC
4710
Flaherty & Crumrine Total Return Fund
FLC
$176M
| $461K | ﹤0.01% |
29,197
+287
| +1% | +$4.49K |
|
4711
Cytek Biosciences
CTKB
$621M
| $461K | ﹤0.01% |
45,116
+41,103
| +1,024% | +$552K |
|
|
GLOP
4712
DELISTED
GASLOG PARTNERS LP
GLOP
| $460K | ﹤0.01% |
69,116
-3,710
| -5% | -$27.3K |
|
|
BLU
4713
DELISTED
BELLUS Health Inc.
BLU
| $459K | ﹤0.01% |
55,886
-1,436
| -3% | -$13.4K |
|
4714
Winmark
WINA
$1.26B
| $459K | ﹤0.01% |
1,947
+1,810
| +1,321% | +$431K |
|
4715
Dime Commercial Bancshares
DCOM
$1.81B
| $458K | ﹤0.01% |
14,403
+5,007
| +53% | +$165K |
|
|
BGH
4716
Barings Global Short Duration High Yield Fund
BGH
$285M
| $458K | ﹤0.01% |
36,090
-2,957
| -8% | -$37.7K |
|
|
GUT
4717
Gabelli Utility Trust
GUT
$583M
| $458K | ﹤0.01% |
62,507
-23,753
| -28% | -$163K |
|
|
PRVB
4718
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $457K | ﹤0.01% |
43,249
+11,297
| +35% | +$91.2K |
|
4719
Peoples Bancorp
PEBO
$1.48B
| $457K | ﹤0.01% |
16,170
+4,924
| +44% | +$145K |
|
|
SUMO
4720
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $456K | ﹤0.01% |
56,353
-14,136
| -20% | -$108K |
|
4721
New York Times
NYT
$10.3B
| $456K | ﹤0.01% |
14,060
-6,118
| -30% | -$199K |
|
4722
Hexcel
HXL
$7.74B
| $456K | ﹤0.01% |
7,755
-17,921
| -70% | -$1.03M |
|
4723
Taysha Gene Therapies
TSHA
$1.92B
| $456K | ﹤0.01% |
201,834
+195,562
| +3,118% | +$396K |
|
4724
Portillo's
PTLO
$345M
| $456K | ﹤0.01% |
27,916
-19,037
| -41% | -$381K |
|
|
BRKL
4725
DELISTED
Brookline Bancorp
BRKL
| $455K | ﹤0.01% |
32,166
-1,904
| -6% | -$25.5K |
|
Similar funds
UBS Group's Q4 2022 Portfolio in Review
As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.
- UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
- UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
- UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
- UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
- UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
- UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
- UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.
Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.